Abstract | BACKGROUND: METHODS: Ten morbidly obese patients without type 2 diabetes (3 male, 7 female; body mass index [BMI] 47.92±2.06 kg/m(2)) were evaluated preoperatively and at 6 weeks, 6 months, and 12 months after SG. Total GLP-1, total PYY, insulin, and glucose were measured in fasting state and every 30 minutes after ingestion of 75 g glucose for a total time of 120 minutes. RESULTS: BMI decreased markedly postoperatively (P<.001). Postprandial total GLP-1 and total PYY responses, measured by the area under the curve (AUC), were significantly increased by the sixth postoperative week compared with preoperative period (P<.001). Fasting insulin levels were markedly decreased postoperatively at all time points (all P<.01). Insulin AUC decreased progressively throughout the first postoperative year (P = .04), whereas glucose AUC decreased significantly at 6 and 12 months postoperatively (both P<.01). Insulin sensitivity measured by the Matsuda index increased progressively postoperatively. First phase insulin secretion remained unchanged. CONCLUSION: Postprandial total GLP-1 and total PYY levels increased significantly at 6 weeks post-SG and remained elevated for at least 1 year. These findings may indicate their involvement in better glucose homeostasis and weight loss maintenance after SG.
|
Authors | Dimitris Papamargaritis, Carel W le Roux, Eleni Sioka, George Koukoulis, George Tzovaras, Dimitris Zacharoulis |
Journal | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
(Surg Obes Relat Dis)
2013 Mar-Apr
Vol. 9
Issue 2
Pg. 192-201
ISSN: 1878-7533 [Electronic] United States |
PMID | 23183113
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Blood Glucose
- Gastrointestinal Hormones
- Insulin
- Peptide YY
- Glucagon-Like Peptide 1
|
Topics |
- Adult
- Area Under Curve
- Bariatric Surgery
(methods)
- Blood Glucose
(metabolism)
- Body Mass Index
- Diabetes Mellitus, Type 2
(complications, metabolism)
- Female
- Gastrectomy
(methods)
- Gastrointestinal Hormones
(metabolism)
- Glucagon-Like Peptide 1
(metabolism)
- Homeostasis
(physiology)
- Humans
- Insulin
(metabolism)
- Laparoscopy
(methods)
- Male
- Obesity, Morbid
(complications, metabolism, surgery)
- Peptide YY
(metabolism)
- Postoperative Care
(methods)
- Prospective Studies
|